Infectious Diseases

402 - Adaptive Immune Function and Immunoparalysis in Children With Septic Shock

403 - Association of surfactant protein genetic variants with risk of hospitalization in COVID-19 positive children

404 - Awareness of and Attitudes toward Meningitis among 19–23-Year-Old Young Adults and Parents of 16–18-Year-Old Adolescents

406 - Comparing the Salivary Microbiomes of Children with Pediatric COVID-19, MIS-C, and Controls from the USA and Colombia

407 - Concept elicitation to understand invasive meningococcal disease burden of illness from a patient and caregiver perspective

408 - In Silico Prediction of Plasmodium falciparum PfRipr Epitopes as Vaccine Candidates

409 - iPS cell-derived cardiomyopathy model as the ‘translational hub’ for Chagas disease biomarker discovery: bridging in vitro host-parasite interplay to clinical proof-of-concept.

410 - Longitudinal transcriptome changes during S. epidermidis CSF shunt infection

411 - Monthly Rates and Risk Factors for Invasive Streptococcus pneumoniae Infections in US Military Dependents before and during COVID-19

412 - Parents’/Patients’ Communication with Primary Care Providers on MenB Vaccination for Older Adolescents and Young Adults in the United States

413 - Rates of Invasive Haemophilus influenzae before and during the COVID-19 Pandemic within US Military Dependent Pediatric Population

414 - Selenium deficiency decreases hepatic selenoprotein S expression and exacerbates the hepatic endoplasmic reticulum (ER) stress response after endotoxemia

415 - Antibiotic Resistance and Molecular Epidemiology of Escherichia coli Isolates Producing Neonatal Bacteremia

416 - Are We Dosing Correctly? Pharmacokinetics of Cefepime in Critically Ill Pediatric Patients

417 - Assessment for Differences in Antibiotic Use for Acute Otitis Media in Pediatric Urgent Care

418 - Dual-transcriptomics for characterization of UTI in children with neurogenic bladder who perform clean intermittent catheterization

419 - Dupilumab Treatment of Children with Moderate-to-Severe Atopic Dermatitis Increases Bone Alkaline Phosphatase, a Marker of Bone Mineralization

420 - Dupilumab: A Comparison of Infection Rates across Atopic Dermatitis Trials in Adults, Adolescents, Children, and Infants

421 - Evaluation of Meropenem use at a Pediatric Academic Medical Center

422 - Factors Determining Antibiotic Prescriptions for Pediatric Pneumonia in the Emergency Department

423 - Impact of local antibiogram and infectious disease consult on the care of children with acute hematogenous osteomyelitis and septic arthritis

424 - Patterns and Predictors of Broad-Spectrum Antibiotic Use for Community Acquired Pneumonia in Children Admitted from the Emergency Room

425 - Plasma cell free DNA (cfDNA) Test (Karius Test®) for Diagnosis of Infectious Diseases in Children: A Tertiary Care Children’s Hospital Experience

426 - Risk Factors for UTI Caused by ESBL-Producing Organisms in Children with Anomalies of the Urinary Tract

427 - The Combination of Cefazolin and LL-37 in Extended Spectrum Beta-Lactamase (ESBL) producing E. coli Urinary Tract Infections

428 - Use of plasma next-generation sequencing for the diagnosis of pediatric infectious diseases in the inpatient setting: a single-center experience

429 - Association of reduction in Mean Platelet Volume(MPV) in patients with bronchiolitis with respiratory distress and need for oxygen support

430 - Clinical Features, Radiological Findings and Early Neurodevelopmental Outcomes in Infants with Parechovirus Central Nervous System Infections in the District of Columbia, Maryland, and Virginia

431 - Clinical findings in infants with congenital CMV identified by targeted screening

433 - Herpes simplex virus 2 acute retinal necrosis

434 - Human Parechovirus (HPeV) Infection in Infants Under 3 Months of Age 2018-2022

435 - Impact of Acyclovir Ordering Restriction on Neonatal HSV Evaluations

436 - Invasive Candidiasis in Children with Hematologic Malignancies at a Quaternary Hospital

437 - Invasive Fungal Disease in Pediatric Heart Transplant Recipients: A Single Center Study

438 - Non-severe Multi-system Inflammatory Syndrome-like Illness: Were We Treating this as Incomplete Kawasaki Disease Prior to the Pandemic?

439 - SARS-CoV-2 Transmission and Outcomes at Ten Overnight Youth Summer Camps, United States and Canada, June-August 2022

440 - T2* Weighted Placental Magnetic Resonance Imaging in Pregnant Women Exposed to COVID-19 Infection

614 - Epidemiology and Clinical Spectrum of Pediatric Long COVID in a Dedicated Pediatric COVID Recovery Clinic.

615 - Epidemiology of bronchiolitis among young children in central New York before and after the onset of the COVID-19 pandemic

616 - Exploring the Influence of Pre-Existing Conditions On Patients With Pediatric Long COVID

617 - Immunologic Responses and Clinical Outcomes in Pediatric Solid-Organ Transplant Recipients After SARS-CoV2 Vaccination

618 - Impact of pandemic SARS-Cov-2 in preterm or low birth weight infants followed in three outpatient Kangaroo Mother Care Programs in Colombia.

619 - Impact of the COVID-19 Omicron Variant Outbreak at Nursery Schools in Minato-City, Tokyo, Japan

622 - Placental thrombosis resulting in hypoxic ischemic encephalopathy in an infant of a mother with COVID-19

623 - Risk factors associated with community acquired ESBL urinary tract infections in pediatric patients

624 - SARS-CoV-2 percent positivity and mRNA COVID-19 vaccination coverage among symptomatic children ages 3-17 years— Increasing Community Access to Testing (ICATT) Program, August-December 2022

626 - Single-cell RNA-sequencing reveals RSV- and SARS-CoV-2-specific cell states within the nasal mucosa of young children presenting to the emergency department

627 - Unique patterns of SARS-CoV-2 immunity in vaccinated children

628 - Use of Monoclonal Antibodies for the Treatment of COVID-19 in Pediatric Patients: Single Center Study

629 - A Geospatial Analysis of Community-Acquired Extended-Spectrum Beta-Lactamase Urinary Tract Infections in Children Living in the Washington Metropolitan Area

630 - Characteristics of Respiratory Syncytial Virus in Children Aged 0-5 Years Before and During COVID-19 Pandemic in an Urban Multiethnic Community Hospital

631 - Comparing the Epidemiology of COVID-19 with other Common Respiratory Viruses in Pediatric Patients

632 - Contemporary Enterovirus-D68 Infects Human Spinal Cord Organoids

634 - Eleven Years of Experience with Pediatric Histoplasmosis at a Tertiary Children’s Hospital in an Endemic Area

635 - Families’ Perceptions of Barriers to Pediatric Latent Tuberculosis Care Engagement: A Mixed-Methods Study

636 - Incidence of Infectious Mononucleosis and Associated Hospitalizations Between 2010 and 2021 in an Upper Midwest Population

637 - Infant hospitalizations and ICU Admissions for Bronchiolitis and RSV-BRONCHIOLITIS are at historic highs during 2022 early seasonal disease: results from Four US health systems

638 - Maternal syphilis and congenital syphilis during COVID-19 pandemic: Case-Control Study in Brooklyn, New York 2012 – 2021

639 - Respiratory pathogen surveillance in pediatric health care workers

640 - School Absenteeism as a Marker for Community Covid-19 Rates

642 - Seasonality of Infant Lower Respiratory Tract Infections, Including those Caused by RSV, Was Altered During the COVID-19 Pandemic: Results from Four US Health Systems

643 - Single-Center Tertiary-Level Children’s Hospital Experience with a Measles Outbreak in Columbus, Ohio

644 - Six-fold increase in the incidence of Congenital Syphilis in U.S Neonatal ICUs